Recent News

• 02.12.2026 - IDEXX Laboratories to Present at Two Institutional Investor Conferences
• 02.02.2026 - IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results
• 01.15.2026 - Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus
• 01.15.2026 - IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs
• 01.13.2026 - IDEXX Announces CEO Succession
• 01.09.2026 - IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results

Recent Filings

• 02.13.2026 - 8-K Current report
• 02.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.10.2026 - 144 Report of proposed sale of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.02.2026 - 8-K Current report
• 02.02.2026 - EX-99.1 EX-99.1
• 01.13.2026 - 8-K Current report
• 01.13.2026 - EX-99.1 EX-99.1
• 12.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.13.2025 - 8-K Current report